Page last updated: 2024-10-28

hexoprenaline and Abortion, Threatened

hexoprenaline has been researched along with Abortion, Threatened in 2 studies

Hexoprenaline: Stimulant of adrenergic beta 2 receptors. It is used as a bronchodilator, antiasthmatic agent, and tocolytic agent.

Abortion, Threatened: UTERINE BLEEDING from a GESTATION of less than 20 weeks without any CERVICAL DILATATION. It is characterized by vaginal bleeding, lower back discomfort, or midline pelvic cramping and a risk factor for MISCARRIAGE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strizhakov, AN1
Medvedev, MV1
Kovaleva, LG1
Reinold, E1

Other Studies

2 other studies available for hexoprenaline and Abortion, Threatened

ArticleYear
[Uterine-placental-fetal blood flow and fetal cardiac activity during the ginipral treatment of premature labor].
    Akusherstvo i ginekologiia, 1993, Issue:2

    Topics: Abortion, Threatened; Adult; Drug Evaluation; Female; Fetal Heart; Fetus; Hexoprenaline; Humans; Obs

1993
[Tocolysis in the first half of pregnancy].
    Wiener medizinische Wochenschrift (1946), 1988, May-15, Volume: 138, Issue:9

    Topics: Abortion, Threatened; Adult; Bed Rest; Female; Hexoprenaline; Humans; Pregnancy; Pregnancy Trimester

1988